Cargando…

No More Venous Ulcers—What More Can We Do?

Venous leg ulcers (VLUs) are the most severe complication caused by the progression of chronic venous insufficiency. They account for approximately 70–90% of all chronic leg ulcers (CLUs). A total of 1% of the Western population will suffer at some time in their lives from a VLU. Furthermore, most C...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanek, Agata, Mosti, Giovanni, Nematillaevich, Temirov Surat, Valesky, Eva Maria, Planinšek Ručigaj, Tanja, Boucelma, Malika, Marakomichelakis, George, Liew, Aaron, Fazeli, Bahar, Catalano, Mariella, Patel, Malay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573394/
https://www.ncbi.nlm.nih.gov/pubmed/37834797
http://dx.doi.org/10.3390/jcm12196153
_version_ 1785120452450975744
author Stanek, Agata
Mosti, Giovanni
Nematillaevich, Temirov Surat
Valesky, Eva Maria
Planinšek Ručigaj, Tanja
Boucelma, Malika
Marakomichelakis, George
Liew, Aaron
Fazeli, Bahar
Catalano, Mariella
Patel, Malay
author_facet Stanek, Agata
Mosti, Giovanni
Nematillaevich, Temirov Surat
Valesky, Eva Maria
Planinšek Ručigaj, Tanja
Boucelma, Malika
Marakomichelakis, George
Liew, Aaron
Fazeli, Bahar
Catalano, Mariella
Patel, Malay
author_sort Stanek, Agata
collection PubMed
description Venous leg ulcers (VLUs) are the most severe complication caused by the progression of chronic venous insufficiency. They account for approximately 70–90% of all chronic leg ulcers (CLUs). A total of 1% of the Western population will suffer at some time in their lives from a VLU. Furthermore, most CLUs are VLUs, defined as chronic leg wounds that show no tendency to heal after three months of appropriate treatment or are still not fully healed at 12 months. The essential feature of VLUs is their recurrence. VLUs also significantly impact quality of life and could cause social isolation and depression. They also have a significant avoidable economic burden. It is estimated that the treatment of venous ulceration accounts for around 3% of the total expenditure on healthcare. A VLU-free world is a highly desirable aim but could be challenging to achieve with the current knowledge of the pathophysiology and diagnostic and therapeutical protocols. To decrease the incidence of VLUs, the long-term goal must be to identify high-risk patients at an early stage of chronic venous disease and initiate appropriate preventive measures. This review discusses the epidemiology, socioeconomic burden, pathophysiology, diagnosis, modes of conservative and invasive treatment, and prevention of VLUs.
format Online
Article
Text
id pubmed-10573394
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105733942023-10-14 No More Venous Ulcers—What More Can We Do? Stanek, Agata Mosti, Giovanni Nematillaevich, Temirov Surat Valesky, Eva Maria Planinšek Ručigaj, Tanja Boucelma, Malika Marakomichelakis, George Liew, Aaron Fazeli, Bahar Catalano, Mariella Patel, Malay J Clin Med Review Venous leg ulcers (VLUs) are the most severe complication caused by the progression of chronic venous insufficiency. They account for approximately 70–90% of all chronic leg ulcers (CLUs). A total of 1% of the Western population will suffer at some time in their lives from a VLU. Furthermore, most CLUs are VLUs, defined as chronic leg wounds that show no tendency to heal after three months of appropriate treatment or are still not fully healed at 12 months. The essential feature of VLUs is their recurrence. VLUs also significantly impact quality of life and could cause social isolation and depression. They also have a significant avoidable economic burden. It is estimated that the treatment of venous ulceration accounts for around 3% of the total expenditure on healthcare. A VLU-free world is a highly desirable aim but could be challenging to achieve with the current knowledge of the pathophysiology and diagnostic and therapeutical protocols. To decrease the incidence of VLUs, the long-term goal must be to identify high-risk patients at an early stage of chronic venous disease and initiate appropriate preventive measures. This review discusses the epidemiology, socioeconomic burden, pathophysiology, diagnosis, modes of conservative and invasive treatment, and prevention of VLUs. MDPI 2023-09-23 /pmc/articles/PMC10573394/ /pubmed/37834797 http://dx.doi.org/10.3390/jcm12196153 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Stanek, Agata
Mosti, Giovanni
Nematillaevich, Temirov Surat
Valesky, Eva Maria
Planinšek Ručigaj, Tanja
Boucelma, Malika
Marakomichelakis, George
Liew, Aaron
Fazeli, Bahar
Catalano, Mariella
Patel, Malay
No More Venous Ulcers—What More Can We Do?
title No More Venous Ulcers—What More Can We Do?
title_full No More Venous Ulcers—What More Can We Do?
title_fullStr No More Venous Ulcers—What More Can We Do?
title_full_unstemmed No More Venous Ulcers—What More Can We Do?
title_short No More Venous Ulcers—What More Can We Do?
title_sort no more venous ulcers—what more can we do?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573394/
https://www.ncbi.nlm.nih.gov/pubmed/37834797
http://dx.doi.org/10.3390/jcm12196153
work_keys_str_mv AT stanekagata nomorevenousulcerswhatmorecanwedo
AT mostigiovanni nomorevenousulcerswhatmorecanwedo
AT nematillaevichtemirovsurat nomorevenousulcerswhatmorecanwedo
AT valeskyevamaria nomorevenousulcerswhatmorecanwedo
AT planinsekrucigajtanja nomorevenousulcerswhatmorecanwedo
AT boucelmamalika nomorevenousulcerswhatmorecanwedo
AT marakomichelakisgeorge nomorevenousulcerswhatmorecanwedo
AT liewaaron nomorevenousulcerswhatmorecanwedo
AT fazelibahar nomorevenousulcerswhatmorecanwedo
AT catalanomariella nomorevenousulcerswhatmorecanwedo
AT patelmalay nomorevenousulcerswhatmorecanwedo